This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Physical Therapists Continue Pushing For Consumers' Right To Directly Access Safe And Cost-Effective Services

SACRAMENTO, Calif., March 25, 2013 /PRNewswire/ -- California physical therapists continue fighting for the right of California consumers to directly access quality, cost-effective and safe physical therapy services. Assembly Bill 1000, authored by Assemblymember Bob Wieckowski (D- Fremont) and sponsored by the California Physical Therapy Association (CPTA), once again puts direct access to quality physical therapist services on the radar of California legislators. "Our health care delivery system is under 'a microscope' right now as our policymakers look for ways to increase accessibility and affordability of care," said Dr. James Syms, PT, DSc, ATC, SCS and President of CPTA. "We believe in the right of consumers to choose a qualified provider for timely, safe and cost-effective physical therapist services and will continue to drive toward this right."

AB 1000 allows consumers access to physical therapist services without delay by amending the Business and Professions Code Section 2620 to include in the definition of physical therapy the examination and evaluation of an individual to determine a physical therapy diagnosis, prognosis, treatment plan, instruction or consultative services.

"Through the passage of this bill, consumers would be able to choose and access timely health care services," said Syms. "They would be able to receive immediate physical therapy treatment, which often is delayed by having to pass through traditional gatekeepers."

Syms continued, "Physical therapists are well trained, many at the doctorate level. As experts in human function and mobility, we are skilled clinicians in examining, evaluating and classifying impairments for and treating patients. AB 1000 allows us to use our skills to the greatest degree for the benefit of California residents.

This bill is consistent with the Senate Office of Research and the Senate Health Committee report, which recommends health care providers be allowed to practice at "the top of their license."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs